These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 10709170

  • 1. Low-dose intratympanic gentamicin treatment for dizziness in Ménière's disease.
    Longridge NS, Mallinson AI.
    J Otolaryngol; 2000 Feb; 29(1):35-9. PubMed ID: 10709170
    [Abstract] [Full Text] [Related]

  • 2. Intratympanic gentamicin for intractable Meniere's disease.
    Perez N, Martín E, García-Tapia R.
    Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
    [Abstract] [Full Text] [Related]

  • 3. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC, Minor LB.
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [Abstract] [Full Text] [Related]

  • 4. Intratympanic gentamicin titration therapy for intractable Meniere's disease.
    Atlas JT, Parnes LS.
    Am J Otol; 1999 May; 20(3):357-63. PubMed ID: 10337978
    [Abstract] [Full Text] [Related]

  • 5. [Intratympanic gentamicin treatment for intractable Menière's disease].
    Gilony D, Wolf M, Kronenberg J.
    Harefuah; 2004 Jan; 143(1):4-7, 88. PubMed ID: 14748278
    [Abstract] [Full Text] [Related]

  • 6. Long-term disability of class A patients with Ménière's disease after treatment with intratympanic gentamicin.
    Boleas-Aguirre MS, Sánchez-Ferrandiz N, Guillén-Grima F, Perez N.
    Laryngoscope; 2007 Aug; 117(8):1474-81. PubMed ID: 17607149
    [Abstract] [Full Text] [Related]

  • 7. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.
    Derebery MJ, Fisher LM, Berliner K, Chung J, Green K.
    Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498
    [Abstract] [Full Text] [Related]

  • 8. Intratympanic gentamicin injection for the treatment of Meniere's disease.
    Youssef TF, Poe DS.
    Am J Otol; 1998 Jul; 19(4):435-42. PubMed ID: 9661751
    [Abstract] [Full Text] [Related]

  • 9. Intentional ablation of vestibular function using commercially available topical gentamicin-betamethasone eardrops in patients with Meniere's disease: further evidence for topical eardrop ototoxicity.
    Kaplan DM, Hehar SS, Bance ML, Rutka JA.
    Laryngoscope; 2002 Apr; 112(4):689-95. PubMed ID: 12150525
    [Abstract] [Full Text] [Related]

  • 10. Intratympanic gentamicin therapy for intractable Ménière's disease.
    De Beer L, Stokroos R, Kingma H.
    Acta Otolaryngol; 2007 Jun; 127(6):605-12. PubMed ID: 17503229
    [Abstract] [Full Text] [Related]

  • 11. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease.
    Horii A, Saika T, Uno A, Nishiike S, Mitani K, Nishimura M, Kitahara T, Fukushima M, Nakagawa A, Masumura C, Sasaki T, Kizawa K, Kubo T.
    Otol Neurotol; 2006 Sep; 27(6):896-900. PubMed ID: 16788414
    [Abstract] [Full Text] [Related]

  • 12. Hearing results following intratympanic gentamicin perfusion for Ménière's disease.
    Kyrodimos E, Aidonis I, Sismanis A.
    J Laryngol Otol; 2009 Apr; 123(4):379-82. PubMed ID: 18954493
    [Abstract] [Full Text] [Related]

  • 13. Long-term results after interval therapy with intratympanic gentamicin for Menière's disease.
    Lange G, Maurer J, Mann W.
    Laryngoscope; 2004 Jan; 114(1):102-5. PubMed ID: 14710003
    [Abstract] [Full Text] [Related]

  • 14. Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing.
    Silverstein H, Wazen J, Van Ess MJ, Daugherty J, Alameda YA.
    Otolaryngol Head Neck Surg; 2010 Apr; 142(4):570-5. PubMed ID: 20304280
    [Abstract] [Full Text] [Related]

  • 15. High-dose intratympanic gentamicin instillations for treatment of Meniere's disease: long-term results.
    Hsieh LC, Lin HC, Tsai HT, Ko YC, Shu MT, Lin LH.
    Acta Otolaryngol; 2009 Dec; 129(12):1420-4. PubMed ID: 19922092
    [Abstract] [Full Text] [Related]

  • 16. Intratympanic gentamicin treatment in Meniere's disease: patients' experiences and outcomes.
    Smith WK, Sandooram D, Prinsley PR.
    J Laryngol Otol; 2006 Sep; 120(9):730-5. PubMed ID: 16848921
    [Abstract] [Full Text] [Related]

  • 17. Middle ear exploration in patients with Ménière's disease who have failed outpatient intratympanic gentamicin therapy.
    Crane BT, Minor LB, Della Santina CC, Carey JP.
    Otol Neurotol; 2009 Aug; 30(5):619-24. PubMed ID: 19503016
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Intratympanic gentamicin treatment for unilateral Ménière's disease: long-term follow up of a proven regime.
    Wasson J, Upile N, Pfleiderer A.
    J Laryngol Otol; 2013 Jan; 127(1):20-4. PubMed ID: 23217984
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.